Company intelligence / Profile preview

H.A. Systems Dental Imports

Ramat Gan, Israel

Ownership: Private
Development stage: Other

Overview

H.A. Systems is an established Israeli dental distributor with expertise in launching innovative dental products. The company has secured exclusive distribution rights for OraVerse (phentolamine mesylate), the first and only local anesthesia reversal agent, in Israel and the Palestinian Territories.

Therapeutic areas: Other
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Novalar Pharmaceuticals (distribution agreement for OraVerse in Israel and Palestinian Territories)

Beyond the preview

Go deeper on H.A. Systems Dental Imports.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H.A. Systems Dental Imports.

Explore the full profile